Delivery Order SPE2DB20D2014-SPE2DB25FC47X
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,384 firm-fixed-price delivery order is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of March 18, 2025 and was awarded on March 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,366.98 Firm Fixed Price Delivery Order is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of March 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award, valued at $11,222.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, with a period of performance through January 27, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
- This federal contract award, valued at $8,503.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 100-1,000 MG tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 31, 2024 and is a Firm Fixed Price Delivery Order. This contract is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,114.55 Firm Fixed Price Delivery Order covers the supply of JANUMET XR 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. This award is associated with a larger Indefinite...
- This federal contract award, valued at $1,352.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-500 MG TABLET 180S, a medication used for the treatment of diabetes. The contract is a firm fixed-price Delivery Order and has an ultimate completion date of November 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen, the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,180.11 firm-fixed-price delivery order is for the supply of 4564885820 JANUMET XR 100-1,000 MG TABLET 90S, a medical product used in the treatment of diabetes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
- This federal contract award is a delivery order valued at $14,103.96 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Janumet XR 50-1,000 mg tablets, a medication used to treat diabetes. The contract has a non-set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,126.38, is a Firm Fixed Price Delivery Order for the supply of JANUMET XR 100-1,000 MG TABLET 90S, a medication used in the treatment of diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,119.69 delivery order contract is for the supply of JANUMET XR 100-1,000 MG TABLET 90S, a prescription medication. The contract has a completion date of July 3, 2025 and is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC47XDelivery Order
This federal contract award is a delivery order valued at $13,127.64 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a medication used to treat diabetes. The award has a firm fixed price and an ultimate completion date of July 17, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract award was not set-aside and was competitively awarded, indicating AmerisourceBergen Drug Corp's capability to meet federal procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 7/16/25 |